Taipei Fertility Center

What Taipei Fertility Center does

Taipei Fertility Center (TFC) is a private, physician-led reproductive medicine clinic headquartered in Taipei, Taiwan, operating under the legal entity Taipei Medical Technology Co., Ltd. Founded in 2019 as the branded clinic of Professor Chii-Ruey Tzeng — recognized as the 'Father of IVF in Taiwan' for delivering Taiwan's first IVF baby in 1985 — TFC consolidates decades of reproductive medicine practice into a three-location operation across Taipei (Xinyi District), Songren, and Banqiao. The center provides comprehensive fertility services including in vitro fertilization (IVF), intrauterine insemination (IUI), egg and sperm freezing via vitrification, donor gamete programs, hysteroscopy, recurrent miscarriage evaluation, and integrated support services spanning Traditional Chinese Medicine, psychological counseling, and nutrition. Its laboratory stack includes Time-Lapse Embryo Incubators (continuous imaging every 10 minutes), an AI-powered embryo selection model reported to improve chromosomally normal embryo identification by up to 24%, Endometrial Receptivity Analysis (ERA), and PGT-A/PGS genetic screening, supporting reported IVF pregnancy rates of approximately 60% cumulatively and nearly 70% for women under 38.

TFC's revenue model is built on per-cycle unit pricing for clinical procedures (IVF at NT$180,000-240,000 per cycle, IUI at NT$20,000-50,000 per session, egg freezing at approximately NT$120,000-150,000 with NT$10,000 annual storage) combined with subscription-style recurring storage fees and professional-services revenue from diagnostics and consultations. The clinic reports accompanying 30,000 couples through their IVF journey cumulatively, and serves a notable international patient base of 2,300 cases from 49 countries, supported by a dedicated international medical services team, visa/travel coordination, and a telemedicine program for pre- and post-treatment consultations. Go-to-market combines direct-to-consumer clinic visits with event-driven telemedicine touchpoints and sales-led international patient coordination, marketed through a multi-channel digital presence spanning Facebook, LINE, Instagram, YouTube, WeChat, Weibo, Xiaohongshu, WhatsApp, and the TFC mobile app.

TFC holds Taiwan's only SNQ (Symbol of National Quality) certification for a fertility center and a National Invention Award Gold Medal (2009) for its endometriosis reagent patent. Revenue and ownership are not publicly disclosed; the company is privately held with no parent entity, no external funding rounds, and no M&A activity recorded in the input data. The competitive positioning rests on a talent moat anchored by Dr. Tzeng's pioneer credentials, an intangible-asset moat from SNQ certification and decades of clinical outcomes, and a distribution moat in cross-border fertility tourism.

Name

Taipei Fertility Center

Legal name

Taipei Medical Technology Co., Ltd. (台北醫學科技股份有限公司)

Website

https://tfcivf.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

11–50 employees

Short description

Taipei Fertility Center (TFC) is a private, Taipei-based reproductive medicine clinic led by Dr. Chii-Ruey Tzeng, the pioneer of IVF in Taiwan. It offers IVF, IUI, egg/sperm freezing, donor programs, and integrated TCM and psychological support across three clinics, serving domestic patients and international medical tourists from 49 countries.

Ownership category

akta.pro rank

Product category

Reproductive Medicine / Fertility Services

NAICS

Family Planning Centers (621410)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Fertility treatments
• IVF services
• Reproductive medicine
• Fertility preservation
• Assisted reproduction

Headquarters

HQ city

Taipei City

HQ country

Taiwan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. IVF (In Vitro Fertilization) Treatment: Complete IVF treatment cycles including ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer. One-time treatment cycles with high average transaction value.
2. IUI (Intrauterine Insemination): Artificial insemination services with sperm processing and uterine insemination. Lower cost per cycle compared to IVF.
3. Egg and Sperm Freezing: Egg retrieval and vitrification freezing services with annual storage fees. Initial procedure plus recurring annual storage revenue.
4. Medical Consultations and Diagnostics: Fertility consultations, diagnostic tests including AMH testing, ultrasound, semen analysis, and fertility health checkup packages.
5. Egg/Sperm Donation Program: Donor egg and sperm services for couples requiring donor reproductive materials.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Core offering

Taipei Fertility Center provides comprehensive assisted reproductive technology services including In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg and sperm freezing via vitrification, donor gamete programs, hysteroscopy, and recurrent miscarriage treatment. The center combines advanced laboratory technologies (AI-powered embryo selection, time-lapse incubators, PGT-A, ERA) with integrated supportive care including Traditional Chinese Medicine, nutrition counseling, and psychological counseling, serving both domestic Taiwanese patients and international medical tourists from over 49 countries.

Product overview

Taipei Fertility Center operates as a comprehensive reproductive medicine center offering a unified platform of fertility services centered around assisted reproductive technologies. The core portfolio includes In Vitro Fertilization (IVF) with advanced embryo selection capabilities and Intrauterine Insemination (IUI) as the primary treatment modalities, complemented by fertility preservation through egg and sperm freezing using vitrification technology, and donor gamete programs. The center provides diagnostic services including hysteroscopy, infertility consultation, and comprehensive health checkups, alongside advanced laboratory technologies such as time-lapse embryo incubators, PGT-A/PGS genetic screening, and ERA testing. Integrated support services encompass nutrition counseling, psychological support, and traditional Chinese medicine consultations to address holistic patient care throughout the fertility treatment journey.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF) / 試管嬰兒

Quantifiable outcome

• Nearly 70% IVF pregnancy rate for women under 38 years old
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Virtus Health: Largest IVF network in Australia with clinics across Australia, Ireland, the UK, and Singapore. Directly comparable to TFC as a multi-clinic fertility provider combining IVF, IUI, and fertility preservation with cross-border patient reach.
• TMC Fertility Centre (TMC Life Sciences): Malaysian fertility clinic chain within Thomson Medical Group, offering IVF and a range of reproductive services with regional cross-border patient flow. Comparable to TFC as a Southeast Asian multi-clinic fertility operator.
• Monash IVF Group: Australian publicly-listed fertility services provider operating IVF clinics across Australia and internationally. Comparable to TFC on multi-clinic IVF delivery, advanced lab technology adoption, and exposure to medical tourism patient flows.
• Genea: Australian fertility clinic group known for proprietary lab technologies (e.g., Geri time-lapse incubator). Closely comparable to TFC on advanced lab tech positioning and IVF/IUI service delivery to a mix of domestic and international patients.
• Prelude Fertility (Inception Fertility): US-based fertility clinic network providing IVF, egg freezing, and related reproductive services across multiple locations. Comparable to TFC as a multi-clinic fertility operator with standardized lab technology.
• Kindbody: US-based fertility clinic chain offering IVF, IUI, egg freezing, and gynecology with employer-facing benefits. Comparable to TFC on integrated clinic-and-tech model and modern brand positioning for fertility patients.
• Jetanin Institute: Leading Thailand-based fertility clinic serving large international patient volumes, particularly from China and the Middle East. Directly comparable to TFC as an Asia-focused fertility clinic that monetizes cross-border medical tourism.

Broad incumbents

• Bumrungrad International Hospital: Major Thailand-based international hospital with a fertility center serving high volumes of medical tourists, particularly from the Middle East and Greater China. Comparable to TFC as a broader Asia medical-tourism destination with a fertility service line.

Emerging players

• Carrot Fertility: US-based fertility benefits and care-navigation platform that partners with clinics and employers. Adjacent to TFC's model: not a clinic itself, but routes employer-sponsored fertility patients to partner clinics — relevant as both a competitor and a potential patient-acquisition channel.
• Maven Clinic: Digital women's and family health platform offering virtual care including fertility, pregnancy, and postpartum support. Comparable to TFC's telemedicine program and overlapping patient demographic, though operating in a virtual-first model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/TFC66720691
• YouTubeyoutube.com/channel/UC4LwxzuzRqwSpa1A64eziDQ
• Facebookfacebook.com/tfcivf
• Instagraminstagram.com/tfc.ivf
• LinkedInlinkedin.com/company/taipei-fertility-center

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Taipei Fertility Center